Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis
Marianna Cortese(Harvard University), Alberto Ascherio(Brigham and Women's Hospital), Stephen J. Elledge(Howard Hughes Medical Institute), Moriah Mitchell(Brigham and Women's Hospital), Brian C. Healy(Evidence (Italy)), Yumei Leng(Howard Hughes Medical Institute), Kjetil Bjørnevik(Harvard University), Kassandra L. Munger(Biogen (United States)), James D. Mancuso(Uniformed Services University of the Health Sciences), David W. Niebuhr(Uniformed Services University of the Health Sciences), Michael J. Mina(Harvard College Observatory)
Cited by 35
Related Papers
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
|New England Journal of Medicine|1993|2.4k
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
|Cell|1995|2.1k
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
|Science|2022|2k
Dietary Fiber, Glycemic Load, and Risk of NIDDM in Men
|Diabetes Care|1997|1.4k